A year after supplementation began, only 10% of the foals were affected
Clinical Update 2/12/2026 Brain Benefits from Soda
This combinatorial approach may ultimately prove more flexible than the all-in-one triple-agonist strategy, because it allows each component to be dosed independently and titrated to individual response
All patients completed clinical assessments except one SZ patient who refused the PANSS and BACS assessments, and one BP patient who refused the PANSS assessment
The combination with Cagrilintide is not studied in the literature and theoretically: Cagrilintide + Tirzepatide would lead to a three-way appetite suppression (GIP + GLP-1 + amylin), potentially supra-additive, but with the risk of strong nausea and loss of muscle mass Cagrilintide + Retatrutide would be a four-way activation, highly speculative For research it is an alternative, not a combination , choose one strategy
Lei HL, Wei HJ, Ho HY, Liao KW, Chien LC